Comparison of a β2-Agonist, Terbutaline, with an Inhaled Corticosteroid, Budesonide, in Newly Detected Asthma
Open Access
- 8 August 1991
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 325 (6) , 388-392
- https://doi.org/10.1056/nejm199108083250603
Abstract
The presence of airway inflammation even in mild asthma points to the potential value of antiinflammatory therapy. We compared the effect of an inhaled corticosteroid, budesonide, with that of an inhaled β2-agonist, terbutaline, in the long-term treatment of newly detected asthma.Keywords
This publication has 13 references indexed in Scilit:
- Regular inhaled beta-agonist treatment in bronchial asthmaThe Lancet, 1990
- Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol1Journal of Allergy and Clinical Immunology, 1990
- Effect of prednisone and beclomethasone dipropionate on airway responsiveness in asthma: a comparative study.Thorax, 1988
- REBOUND INCREASE IN BRONCHIAL RESPONSIVENESS AFTER TREATMENT WITH INHALED TERBUTALINEThe Lancet, 1988
- Inhaled Corticosteroids Reduce the Severity of Bronchial Hyperresponsiveness in Asthma, But Oral Theophylline Does NotAmerican Review of Respiratory Disease, 1987
- Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthmaJournal of Allergy and Clinical Immunology, 1987
- Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: A comparison between budesonide and terbutalineJournal of Allergy and Clinical Immunology, 1985
- Effect of beclomethasone dipropionate on bronchial responsiveness to histamine in controlled nonsteroid-dependent asthmaJournal of Allergy and Clinical Immunology, 1985
- Asthma and irreversible airflow obstruction.Thorax, 1984
- Peak Expiratory Flow in Normal SubjectsBMJ, 1973